HEOR & Medical Value Liaison (Field-Based)

Pharmacosmos Therapeutics Inc; Phoenix (AZ); Hybrid; USD 225,000 - 261,000; Full time

Job summary

Pharmacosmos Therapeutics Inc. is seeking a Medical Value and Outcomes Liaison (MVOL) to advance scientific exchange and build strategic relationships with national PHDMs and strategic accounts in the US.

This field-based, non-promotional role supports market access strategy through HEOR/RWE evidence for PTI therapies and pipeline products. The MVOL will translate health economics and real-world evidence for stakeholders, collaborating with medical affairs and HEOR teams, and will travel as

Qualifications

• Doctoral degree in health sciences or a Master’s with extensive industry experience
• 2–3+ years of related work experience in MSL, Market Access, Managed Care, or HEOR/RWE
• Strong understanding of the pharmaceutical landscape and managed care
• Knowledge of health economics, outcomes research, and clinical trials
• Proven experience engaging with KOLs or leading medical relationships
• Experience in Hematology/Oncology is preferred
• Knowledge of PhRMA, OIG guidelines; ICH-GCP familiarity

Responsibilities

• Serve as a primary field medical lead, generating scientific discussions with national networks
• Develop KOL and PHDM relationships across strategic account segments
• Support market access strategy and HEOR/RWE data generation in collaboration with medical affairs
• Identify opportunities for HEOR/RWE data generation and publication plans
• Gather insights to improve pathway inclusion and reduce barriers to therapy
• Enhance reporting of field medical activities and value demonstrated

Skills

Customer-oriented

Excellent communication skills

Responsible

Transparency

Accountability

Ability to act locally

Education

PharmD / MD / PhD or Master's in health sciences

Job description

Pharmacosmos Therapeutics Inc. is seeking a Medical Value and Outcomes Liaison (MVOL) to advance scientific exchange and build strategic relationships with national PHDMs and strategic accounts in the US.

This field-based, non-promotional role supports market access strategy through HEOR/RWE evidence for PTI therapies and pipeline products. The MVOL will translate health economics and real-world evidence for stakeholders, collaborating with medical affairs and HEOR teams, and will travel as